Novo Nordisk faces US scrutiny over drug prices

US Senator Bernie Sanders is set to grill Novo Nordisk CEO Lars Jorgensen over the prices of Wegovy, the weight loss and diabetes drug, which can cost Americans more than $1,000 a month.

Compartir esta publicacion:

ENTRADAS POPULARES
SÍGANOS
Danos like en facebook
Síganos en Twitter
Suscríbase a nuestro canal
Tik Tok
TRANSMISIÓN EN VIVO